SEC Form D · Amendment · filed October 31, 2016
Alcresta Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Tasos Konidaris · Newton, MAExecSteve Dubin · Newton, MADirectorAlexey D. Margolin · Newton, MADirectorDaniel Tasse · Newton, MAExec · DirectorStephen Krauss · Newton, MADirectorJames Topper · Newton, MADirectorJeremy Lack · Newton, MADirectorRobert Gallotto · Newton, MAExecWilliam Scheinler · Hampton, NJExecBrent Hill · Durham, NCDirectorChad Rakvin · London, United KingdomDirectorBrock Sturdivant · Nashville, TNDirectorBen Melkman · New York, NYDirectorWilliam B. Acheson · Minneapolis, MNDirectorAndrew Cleland · Durham, NCExec · DirectorLight Sky Macro LP · New York, NYExecScot Wingo · Durham, NCExecMartin Paz · Newton, MAExecBlue Anchor Capital Management LLC · Summit, NJDirectorVishal Ghiya · Summit, NJDirectorPeter Farsai · Chico, CAExecRyan Brannon · Chico, CADirectorSteven Hansen · Chico, CADirectorMichael J. Murphy · New York, NYExecTodd Milbourn · New York, NYExec · DirectorDavid Beamish · JOLIET, ILDirectorMartin Paz · Newton, MAExecWilliam Scheinler · Hampton, NJExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗